The clinical presentation and results of the initial biochemical and haematological investigations in 11 newborn term infants with propionic acidaemia are described. All patients had neurological symptoms. Only four had clinically important acidosis, but all had a raised blood ammonia. A diagnosis of propionic acidaemia should be considered in all newborn infants with unexplained neurological deterioration even in the absence of a metabolic acidosis. (Arch Dis Child 1995; 72: F197-F199) 
Propionic acidaemia (PA) is one of the most common inherited disorders of organic acid metabolism.' The disease is caused by a deficiency in the mitochondrial enzyme propionyl CoA carboxylase and leads to an accumulation in propionic acid and other metabolites.2 The clinical phenotype is severe and most affected children present soon after birth. Those who do not die in the newborn period rarely survive beyond their first decade.3 4 The initial presentation in newborn infants is thought almost always to be characterised by a severe metabolic acidosis and it is this finding that usually suggests the diagnosis. We report our experience in which, in most patients presenting with PA, metabolic acidosis was either mild or absent. Time from presentation (days) Figure 1 Serial blood ammonium concentrations from presentation in 11 patients with propionic acidaemia. The broken line represents the normal upper limit of 80 ,Amo/l.
Methods
Between 1986 and 1994, 11 newborn infants with PA, from nine families, were both diagnosed and had their clinical care provided by our unit. The diagnosis was based in 10 cases on finding characteristic metabolites in the urine on analysis by gas chromatography/ mass spectrometry and subsequently confirmed by assay of propionyl CoA carboxylase activity in leucocytes or cultured fibroblasts. One child, whose previous sibling had died from PA, was diagnosed prenatally by assay of propionyl CoA carboxylase in cultured amniocytes. All patients were of Asian origin and in most cases the parents were consanguineous.
A summary of the clinical features at presentation is given in table 1. The median age at presentation was nine days, range one to 22 days. Neurological symptoms were prominent: all but one of the patients had poor feeding or vomiting and most were lethargic. Most were jittery or had frank convulsions. Axial hypotonia was often found on examination.
A summary of the biochemical and haematological abnormalities at initial presentation is given in table 2. Serial measurements of blood ammonia, arterial pH, and bicarbonate are shown in figures 1, 2, and 3, respectively. Hyperammonaemia was found in all children. The median value for the ammonium measurement at the time of presentation was 350 pLmol/l (range 84-1300). Two children had values above 1000 ,umoll. Metabolic acidosis (bicarbonate of < 18 mmol/l) was present in only four children at presentation. The median pH for the group as a whole was 7-39 (range 7- Time from presentation (days) Figure 2 Serial arterial pH values from presentation in 11 patients with propionic acidaemia. The broken line represents the normal lower limit of 7-35. Two patients required peritoneal dialysis. Seven patients were treated with either oral or intravenous L-carnitine. All patients were initially treated with biotin, the co-factor for propionyl CoA carboxylase but none showed any biochemical response. Eight patients survived their initial illness and were subsequently discharged home.
Discussion
The early mortality for children with propionic acidaemia presenting in the newborn period is generally thought to be very high.5 However, with early diagnosis and intensive care support over two thirds of our patients survived. Although most of these children Table 2 Biochemical and haematological abnormalities at presentation in 11 patients with propionic acidaemia Thrombocytopenia and neutropenia are known to occur in propionic acidaemia and are thought to be due to a direct toxic effect of propionic acid on bone marrow proliferation and maturation.7 Although most of our patients had low neutrophil (seven patients) and platelet counts (six patients) during the course of their illness, only a minority were neutropenic or thrombocytopenic at presentation. Similarly, serum calcium concentrations were low initially in only four patients but subsequently in nine.
In conclusion, the diagnosis of an organic acidaemia should be considered in all newborn infants with unexplained neurological deterioration even in the absence of acidosis. A low white cell count, platelet count, and low calcium may support such a diagnosis but may be normal at presentation. The recognition and treatment of hyperammonaemia is likely to be crucial in improving the early outcome for these patients and of particular importance if liver transplantation and, perhaps in the future, gene therapy8 9 are found to be an effective treatment for organic acidaemias. 
